Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting.
about
Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.Molecular characterization of the 98-kilodalton iron-regulated outer membrane protein of Neisseria meningitidis.Humoral immune response to the class 3 outer membrane protein during the course of meningococcal diseaseIntranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccineNeisseria meningitidis lipopolysaccharide modulates the specific humoral immune response to neisserial porins but has no effect on porin-induced upregulation of costimulatory ligand B7-2.Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy.Genetic diversity of penicillin G-resistant Neisseria meningitidis from Spain.Emergence of a new virulent clone within the electrophoretic type 5 complex of serogroup B meningococci in NorwayNeisserial porins inhibit human neutrophil actin polymerization, degranulation, opsonin receptor expression, and phagocytosis but prime the neutrophils to increase their oxidative burstConjugates of synthetic cyclic peptides elicit bactericidal antibodies against a conformational epitope on a class 1 outer membrane protein of Neisseria meningitidisComparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccineHuman antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccineT-cell responses to outer membrane proteins of Neisseria meningitidis: comparative study of the Opa, Opc, and PorA proteins.Membrane protein variations associated with in vitro passage of Borrelia burgdorferiHumoral immune response to class 1 outer membrane protein during the course of meningococcal disease.Clonal distribution of invasive Neisseria meningitidis serogroup C strains circulating from 1976 to 2005 in greater Sao Paulo, Brazil.Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines.Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane proteinCharacterization of the major outer membrane antigens of Treponema hyodysenteriaeImmune responses in mice to different noncovalent complexes of meningococcal B polysaccharide and outer membrane proteins.Antibody response of swine to outer membrane components of Haemophilus pleuropneumoniae during infectionAntibody response in group B meningococcal disease determined by enzyme-linked immunosorbent assay with serotype 15 outer membrane antigenHuman immunoglobulin G subclass immune response to outer membrane antigens in meningococcal group B vaccine.Characterization of serogroup A and B strains of Neisseria meningitidis with serotype 4 and 21 monoclonal antibodies and by multilocus enzyme electrophoresis.Immunological and molecular characterization of three variant subtype P1.14 strains of Neisseria meningitidis.Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.Antibodies to meningococcal class 1 outer membrane proteins in South African complement-deficient and complement-sufficient subjects.Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination.Deduced amino acid sequences of class 1 protein (PorA) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.
P2860
Q30175865-5E27E7CC-F2A0-4FA3-8AB5-503D387EC030Q33614142-BB87B744-4B39-4E83-B4C8-9334CABED970Q33614175-4AD5FD0E-9C9F-42A2-9DDC-D4DE1A9E7342Q33752052-7E86C167-EFC1-44CA-B429-D88ECFA8B009Q33756300-57EAA08A-5AD8-47BC-8480-E4912972A0A3Q34000420-06A765B6-B18E-44E4-AF1B-157923327F23Q34008652-7B49C805-1F41-48F2-AF35-ED62250EAED4Q34541047-5A80F00A-65AF-4130-9DD7-54EAD12E3B9FQ35093536-DD442DD5-E071-4568-B451-C8597C89477CQ35224452-3139D90B-BDD0-4B57-AB64-8B985ECBCAFAQ35379174-3AB6DF9C-E47A-4474-90D5-796847DF3218Q35436549-44F9B067-619A-4462-B993-698143F63429Q35437531-219F7632-3565-48AD-8206-466E02404311Q35454550-59A2B1AF-D43B-4E9A-968F-0E79FCFC3690Q35464174-6CADB39C-0A37-4100-B801-36CEFCED2F26Q35465724-D6C27530-26DF-45A6-B7D9-39BEA001C4ADQ35777121-41092B5E-B503-4E27-AFAB-CC2D7061C243Q35784362-2CD8B25E-C2CF-404D-8614-64A786B9023AQ35946901-79AB8229-3FB9-4A53-A27E-6EDE79648F1BQ36949061-2A3A1517-7FF0-4A79-AB1D-F544DE91BCDAQ37001390-A504660C-5049-45C8-A74E-EDACA1B41DF7Q37002443-C3878061-0487-4276-BE76-CBD3D6FF6966Q37013973-96DC725A-0949-4653-9FA1-6F889C42CFCCQ37213235-3159E518-44AD-41AE-8F79-F2E04CAE03D4Q37216248-27490D7A-576F-47BB-A022-A3A178A42F1CQ37240084-E96449B9-D631-4807-AE87-92AC4468DA4BQ39571937-7E117D6E-8E86-4B44-8E02-0939028DCE30Q40120418-CB62F15F-A2EE-4132-88B5-80BAAEABAAA3Q40152035-75C4E5E9-B364-4954-ACA1-6089E1932CA1Q40427078-765702BB-6C21-4FF9-B020-0466CBD28046Q41897752-0F918645-1A82-46E4-A8C4-6945DC7D92D6
P2860
Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human antibody response to a g ...... determined by immunoblotting.
@en
Human antibody response to a g ...... determined by immunoblotting.
@nl
type
label
Human antibody response to a g ...... determined by immunoblotting.
@en
Human antibody response to a g ...... determined by immunoblotting.
@nl
prefLabel
Human antibody response to a g ...... determined by immunoblotting.
@en
Human antibody response to a g ...... determined by immunoblotting.
@nl
P2860
P1476
Human antibody response to a g ...... determined by immunoblotting.
@en
P2093
P2860
P304
P407
P577
1986-02-01T00:00:00Z